IL132032A0 - Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus - Google Patents
Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitusInfo
- Publication number
- IL132032A0 IL132032A0 IL13203298A IL13203298A IL132032A0 IL 132032 A0 IL132032 A0 IL 132032A0 IL 13203298 A IL13203298 A IL 13203298A IL 13203298 A IL13203298 A IL 13203298A IL 132032 A0 IL132032 A0 IL 132032A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- diabetes mellitus
- dependent diabetes
- insulin dependent
- related molecules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physical Vapour Deposition (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3560497P | 1997-03-24 | 1997-03-24 | |
| PCT/US1998/005591 WO1998042340A1 (en) | 1997-03-24 | 1998-03-24 | Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL132032A0 true IL132032A0 (en) | 2001-03-19 |
Family
ID=21883695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13203298A IL132032A0 (en) | 1997-03-24 | 1998-03-24 | Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1019049A1 (en) |
| JP (1) | JP2001521551A (en) |
| KR (1) | KR20010005678A (en) |
| CN (1) | CN1256630A (en) |
| AU (1) | AU6576398A (en) |
| BR (1) | BR9808054A (en) |
| CA (1) | CA2284192A1 (en) |
| IL (1) | IL132032A0 (en) |
| NO (1) | NO994612L (en) |
| NZ (1) | NZ337927A (en) |
| WO (1) | WO1998042340A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ2937A1 (en) * | 1998-11-12 | 2004-03-15 | Smithkline Beecham Plc | New compositions of insulin sensitizers. |
| WO2000028989A1 (en) * | 1998-11-12 | 2000-05-25 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| WO2002100396A1 (en) * | 2001-06-07 | 2002-12-19 | Wyeth | COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT |
| WO2005070413A1 (en) * | 2004-01-23 | 2005-08-04 | Japan Science And Technology Agency | Retinoic acid-containing remedy for diabetes |
| US11191755B2 (en) | 2014-01-17 | 2021-12-07 | Cornell University | Compositions and methods for providing cardioprotective effects |
| CA2937107C (en) | 2014-01-17 | 2020-12-22 | Cornell University | Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04504847A (en) * | 1989-03-08 | 1992-08-27 | ザ ユニバーシティ オヴ バージニア パテント ファウンデーション | Dietary supplements for insulin resistant diabetes |
| FR2695317B1 (en) * | 1992-09-07 | 1995-03-10 | Monal Lab | Composition capable of stimulating the secretion of insulin intended for the treatment of non-insulin-dependent diabetes. |
| EP0612529B1 (en) * | 1993-01-22 | 2000-04-05 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Therapeutic agent for NIDDM |
| US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| US5444086A (en) * | 1994-03-31 | 1995-08-22 | American Home Products Corporation | Naphthalenylmethyl thiophenones as antihyperglycemic agents |
-
1998
- 1998-03-24 BR BR9808054-7A patent/BR9808054A/en not_active Application Discontinuation
- 1998-03-24 KR KR1019997008746A patent/KR20010005678A/en not_active Application Discontinuation
- 1998-03-24 EP EP98911919A patent/EP1019049A1/en not_active Withdrawn
- 1998-03-24 WO PCT/US1998/005591 patent/WO1998042340A1/en not_active Application Discontinuation
- 1998-03-24 AU AU65763/98A patent/AU6576398A/en not_active Abandoned
- 1998-03-24 NZ NZ337927A patent/NZ337927A/en unknown
- 1998-03-24 IL IL13203298A patent/IL132032A0/en unknown
- 1998-03-24 JP JP54585198A patent/JP2001521551A/en active Pending
- 1998-03-24 CA CA002284192A patent/CA2284192A1/en not_active Abandoned
- 1998-03-24 CN CN98805131A patent/CN1256630A/en active Pending
-
1999
- 1999-09-22 NO NO994612A patent/NO994612L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ337927A (en) | 2000-11-24 |
| AU6576398A (en) | 1998-10-20 |
| CN1256630A (en) | 2000-06-14 |
| JP2001521551A (en) | 2001-11-06 |
| BR9808054A (en) | 2000-11-07 |
| WO1998042340A1 (en) | 1998-10-01 |
| EP1019049A1 (en) | 2000-07-19 |
| KR20010005678A (en) | 2001-01-15 |
| NO994612D0 (en) | 1999-09-22 |
| CA2284192A1 (en) | 1998-10-01 |
| NO994612L (en) | 1999-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA981343B (en) | Sulfonylurea-glitazone combinations for diabetes | |
| EP1010432A4 (en) | Remedies for diabetes | |
| AU6479596A (en) | Methods for treating diabetes | |
| AU3917995A (en) | Teeth-coating liquid | |
| AU5743896A (en) | Electrochemiluminescent platform molecules | |
| AU4232097A (en) | Set screw for use with osteosynthesis apparatus | |
| AU1981895A (en) | Absorption process without external solvent | |
| AU1450900A (en) | Methods of treatment of type 2 diabetes | |
| AU3731995A (en) | Hypoglycemic agent from cryptolepis | |
| AU3236895A (en) | Aspb1 insulin analogs | |
| NO983770D0 (en) | Therapeutic agent for diabetes | |
| AU1405595A (en) | Use of thalidomide for the treatment of non-insulin dependent diabetes mellitus | |
| IL132032A0 (en) | Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus | |
| AU6998196A (en) | Medicinal composition for diabetes | |
| AU2205099A (en) | Chimeric proteins for the treatment of diabetes | |
| AU1338395A (en) | Pyridinium compounds | |
| AU3559195A (en) | Case for personal use | |
| GB9606076D0 (en) | Diabetes treatment | |
| AU6258894A (en) | Chimeric gene using the gene or cdna of insuline, specially for the gene therapy of diabetes | |
| AU3117497A (en) | Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus | |
| AUPM885894A0 (en) | Therapeutic molecules | |
| SI0869785T1 (en) | 4-hydroxycoumarin-3-carboxamides for the treatment of non-insulin dependent diabetes mellitus | |
| PL348152A1 (en) | Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus | |
| AU4938096A (en) | Gas-heatable appliance for personal use | |
| AU7181198A (en) | Assays for non-insulin dependent diabetes |